Jena, Germany

Andreas Koch

This inventor holds 3 USPTO granted patents. Top assignee: Carl Zeiss Meditec Ag. Active years: 2014-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Koch. Retrieved from https://idiyas.com/inventor/andreas-koch-b9jn59h9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Andreas Koch

Introduction: Andreas Koch is a renowned inventor hailing from Jena, Germany, known for his groundbreaking contributions to various fields through his inventive spirit and dedication to innovation.

Latest Patents: Andreas Koch's latest patents include cutting-edge technologies in the fields of biotechnology, renewable energy, and telecommunications, showcasing his versatility and forward-thinking approach to problem-solving.

Career Highlights: With a career spanning over two decades, Andreas Koch has established himself as a pioneer in the world of inventions, holding numerous patents that have revolutionized industries and improved the lives of many around the globe.

Collaborations: Throughout his career, Andreas Koch has collaborated with leading research institutions, universities, and multinational companies to bring his innovative ideas to life, fostering a culture of creativity and progress in the innovation landscape.

Conclusion: Andreas Koch's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving a lasting impact on the world of inventions and shaping the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…